Graeme Griffin
8Patents
3h-index
7Co-inventors
42Inventor score
Filing activity: May 6, 2004 → Feb 10, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7083933B1 | Methods for identification of modulators of OSGPR116 activity | Physics | 42 | Expired |
| US7651687B2 | Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tumor cells to the effects of EGFR kinase inhibitors | Human Necessities | 22 | Active |
| US8093011B2 | Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors | Physics | 10 | Expired |
| US8114846B2 | Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tumor cells to the effects of EGFR kinase inhibitors | Human Necessities | 2 | Active |
| US7879566B2 | Methods for the identification of modulators of OSGPR114 or OSGPR78 activity, and their use in the treatment of disease | Physics | 0 | Active |
| US9244058B2 | Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors | Physics | 0 | Active |
| US7524638B1 | Methods for identification of modulators of OSGPR114 or OSGPR78 activity, and their use in the treatment of disease | Physics | 0 | Expired |
| US8586546B2 | Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tumor cells to the effects of EGFR kinase inhibitors | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.